INS and sarcopenia: Consequently, a vicious cycle is created in which these losses lead to decreased muscle surface area for glucose transport and storage, along with the inability of muscle to respond to insulin released by pancreas, further worsening glucose dyshomeostasis and feeding the pathways which accelerate loss of muscle strength and mass (sarcopenia), at which point the cycle starts again [40].